ZENOVIVE
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75614098 |
| Registration Number | 2718310 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Domestic Representative | GLAXOSMITHKLINE |
| Attorney Name | SHELDON R. PONTAOE |
| Law Office Assigned | L50 |
| Employee Name | SAPPENFIELD, ANN ELIZA |
Timeline
| 1998-12-28 | Application Filed |
| 2000-03-28 | Published for Opposition |
| 2003-05-27 | Trademark Registered |
| 2008-05-22 | Location: SCANNING ON DEMAND |
| 2010-01-02 | Cancelled |
| 2010-01-02 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Address | Glaxo Wellcome House Berkeley Avenue Greenford, Middles GB |
| Legal Entity Type | Corporation |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations for the treatment of cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1999-06-29 | 1 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1999-07-02 | 2 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1999-07-06 | 3 DOCK D:Assigned to Examiner |
| PETITION TO REVIVE-RECEIVED | 2001-05-02 | 4 PETR I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1999-12-20 | 6 CNSA P: |
| NOTICE OF PUBLICATION | 2000-02-25 | 7 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2000-03-28 | 8 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2000-06-20 | 9 NOAM O:Outgoing Correspondence |
| ABANDONMENT - NO USE STATEMENT FILED | 2001-04-24 | 10 ABN6 S: |
| PETITION TO REVIVE-RECEIVED | 2001-02-09 | 11 PETR I:Incoming Correspondence |
| REINSTATED | 2001-07-13 | 12 REIN O:Outgoing Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2000-12-20 | 13 IUCN S: |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2001-09-04 | 14 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 2002-03-01 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2002-03-17 | 16 EX1G S: |
| TEAS EXTENSION RECEIVED | 2002-08-20 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2002-08-20 | 18 EXT2 S: |
| EXTENSION 2 GRANTED | 2002-10-11 | 19 EX2G S: |
| TEAS EXTENSION RECEIVED | 2003-03-04 | 20 EEXT I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2003-03-04 | 21 IUCN S: |
| Sec. 1(B) CLAIM DELETED | 2003-03-10 | 22 1.BD I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2003-05-27 | 23 R.PR A:Allowance for Publication |
| CASE FILE IN TICRS | 2008-05-22 | 24 CFIT O:Outgoing Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2010-01-02 | 25 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ZENOVIVE 85500696 not registered Dead/Abandoned |
Glaxo Group Limited 2011-12-21 |
 ZENOVIVE 85460032 4820377 Live/Registered |
Glaxo Group Limited 2011-10-31 |
 ZENOVIVE 75614098 2718310 Dead/Cancelled |
Glaxo Group Limited 1998-12-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 